{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.4","upperLimit":"61.5","value":"40.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"Percent non relapse mortality (actuarial) at analysis in Dec 2011","dispersionType":"95% Confidence Interval","groups":[{"description":"Ex vivo selective depletion of alloreactive donor T lymphocytes utilizing RFT5-SMPT-dgA, a specific anti-interleukin-2 receptor immunotoxin in HLA-matched, nonmyeloablative, peripheral blood stem cell transplantation for hematologic malignancies in older adults","id":"OG000","title":"RFT5-SMPT-dgA, an Anti-interleukin, Used in Transplants"}],"paramType":"NUMBER","populationDescription":"All patients who received the selectively depleted transplant","reportingStatus":"POSTED","timeFrame":"Dec 2011.","title":"Cumulative Non Relapse Mortality","type":"SECONDARY","unitOfMeasure":"percentage of participants"}